CAN LARGE LANGUAGE MODELS SIMULATE HTA COMMITTEE DISCUSSIONS? FINDINGS AND CHALLENGES FROM A CASE STUDY IN NEOADJUVANT TREATMENT OF RESECTABLE NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Reason, T. [1 ]
Klijn, S. [2 ]
Gimblett, A. [1 ]
Malcolm, B. [3 ]
机构：
[1] Estima Sci Ltd, London, England
[2] Bristol Myers Squibb, Utrecht, ZH, Netherlands
[3] Bristol Myers Squibb, London, Middx, England
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
P46
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [21] The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Jiang, Long
    Huang, Jia
    Jiang, Shanshan
    Rong, Wenwen
    Shen, Yaofeng
    Li, Chongwu
    Tian, Yu
    Ning, Junwei
    Chen, Xiaoke
    Yang, Yunhai
    Ding, Zhengping
    Li, Ziming
    Luo, Qingquan
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (08) : 2313 - 2321
  • [22] The surgical perspective in neoadjuvant immunotherapy for resectable non-small cell lung cancer
    Jiang, L.
    Luo, Q.
    ANNALS OF ONCOLOGY, 2020, 31 : S1226 - S1226
  • [23] Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
    Reuss, Joshua E.
    Anagnostou, Valsamo
    Cottrell, Tricia R.
    Smith, Kellie N.
    Verde, Franco
    Zahurak, Marianna
    Lanis, Mara
    Murray, Joseph C.
    Chan, Hok Yee
    McCarthy, Caroline
    Wang, Daphne
    White, James R.
    Yang, Stephen
    Battafarano, Richard
    Broderick, Stephen
    Bush, Errol
    Brock, Malcolm
    Ha, Jinny
    Jones, David
    Merghoub, Taha
    Taube, Janis
    Velculescu, Victor E.
    Rosner, Gary
    Illei, Peter
    Pardoll, Drew M.
    Topalian, Suzanne
    Naidoo, Jarushka
    Levy, Ben
    Hellmann, Matthew
    Brahmer, Julie R.
    Chaft, Jamie E.
    Forde, Patrick M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [24] Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer
    Jay Parekh
    Kaushal Parikh
    Joshua E. Reuss
    Alex Friedlaender
    Alfredo Addeo
    Current Oncology Reports, 2023, 25 : 913 - 922
  • [25] Can Unresectable Non-Small Cell Lung Cancer Become Resectable?
    Chaft, Jamie E.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (06) : 261 - 262
  • [26] Clinical challenges in neoadjuvant immunotherapy for non-small cell lung cancer
    Guo, Hanfei
    Li, Wenqian
    Qian, Lei
    Cui, Jiuwei
    CHINESE JOURNAL OF CANCER RESEARCH, 2021, 33 (02) : 203 - 215
  • [27] Clinical challenges in neoadjuvant immunotherapy for non-small cell lung cancer
    Hanfei Guo
    Wenqian Li
    Lei Qian
    Jiuwei Cui
    ChineseJournalofCancerResearch, 2021, 33 (02) : 203 - 215
  • [28] Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Zhang, Ran
    Zhao, Gang
    You, Jian
    HELIYON, 2023, 9 (09)
  • [29] Neoadjuvant Immuno-Chemotherapy in Resectable Non-Small Cell Lung Cancer - A Retrospective Cohort Study
    Verma, S.
    Vincent, M. D.
    Black, M.
    Nayak, R.
    Cecchini, M.
    Malthaner, R.
    Raphael, J.
    Inculet, R.
    Fortin, D.
    Blanchette, P.
    Kuruvilla, S.
    Qiabi, M.
    Younus, J.
    Breadner, D. A.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S546 - S546
  • [30] Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer
    Zhang, Peng
    Dai, Jie
    Sun, Fenghuan
    Xia, Haoran
    He, WenXin
    Duan, Liang
    Liu, Ming
    Zhao, Deping
    Zhu, Yuming
    Jiang, Gening
    ANNALS OF THORACIC SURGERY, 2022, 114 (03): : 949 - 958
12345